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Introduction {#sec1}
============

Sensitization is a simple form of behavioral plasticity by which exposure to an initial stimulus leads to an enhanced response to a second stimulus. Sensitization is critical for survival, as it allows adjustments to sensory responsiveness in a changing environment, and like other simple forms of plasticity it may serve as a building block for more complex forms of learning and memory. Sensitization has been observed in a variety of organisms from invertebrates to humans ([@bib12], [@bib35], [@bib65]), indicating the importance and widespread conservation of this behavior. Both monoamine and peptide neuromodulators have been implicated in driving this form of plasticity (see, for example, [@bib7], [@bib38]). However, many questions remain concerning the molecular and neural mechanisms of sensitization and how it contributes to behavioral states, in particular to arousal.

Arousal designates a change in behavioral state that enhances vigilance and the ability to respond to appetitive (e.g., food/mates) or aversive (i.e., danger) stimuli. Hallmarks of arousal include sensitization in the form of enhanced sensory acuity, increased motor activity, and greater reactivity to external stimuli. Arousal is a highly conserved, possibly universal feature of animal nervous systems ([@bib34], [@bib56]) and is thought to provide a crucial mechanism through which animals can respond appropriately to their environment. Arousal can be "endogenously generated"; for example, the sleep-wake cycle leads to periods of hyperactive motion and increased neural activity alternating with quiescent periods with lower or altered patterns of neural activity ([@bib19], [@bib37], [@bib45], [@bib75]). Alternatively, "exogenously generated" or environmentally triggered arousal, in which increased attention and responsiveness are evoked by environmental danger signals ([@bib83], [@bib84]), is less well understood. Both forms of arousal are found even in simpler organisms. For example, in flies, environmentally triggered arousal appears to involve neuromodulator signaling via tachykinin-related neuropeptides ([@bib6]) or dopamine, which also modulates sleep-like behavior ([@bib45]). Although studies in invertebrates have recently provided important insights into arousal behaviors (e.g., [@bib23], [@bib44], [@bib51]), in no organism is there a complete picture of how individual neuromodulators act within defined neural circuits to modify behavioral states.

The nematode *C. elegans* provides an excellent system to study the molecular mechanism of sensitization and its contribution to behavioral states such as arousal. *C. elegans* is genetically tractable, is amenable to interrogation of the nervous system at the cellular and whole-organism level, and has a largely complete neuronal connectome. In addition to this "wired" connectome of synapses and gap junctions ([@bib81]), *C. elegans* makes use of a remarkably complex array of neuromodulators ([@bib33], [@bib79]), most of which are known or thought to function extrasynaptically ([@bib10]). This "wireless" connectome of neuromodulatory signaling interactions is involved in the regulation of diverse behaviors ([@bib8]). For example, the G-protein-coupled receptor (GPCR) NPR-1 and its ligands FLP-18 and FLP-21 have been implicated in both environmentally triggered arousal ([@bib29]) and sleep/wake transitions ([@bib22]) in *C. elegans*. Likewise, repeated optogenetic stimulation of the ASH neurons triggers increased forward locomotion, a response that requires the neuropeptide receptor *pdfr-1* ([@bib5]). In each of these cases, neuromodulators appear to modify behavioral outputs in response to changes in the environment, a role that appears generally conserved among animals ([@bib8], [@bib52], [@bib74], [@bib80]). Probing the cellular and molecular effects of neuromodulators on arousal in *C. elegans* may therefore help elucidate general principles through which neuromodulators interact with neural circuits to control complex behavioral states.

Here we describe a new paradigm for arousal in *C. elegans*, evoked in response to mechanosensory stimulation. We find that in addition to an acute escape reflex, an aversive mechanical stimulus leads to increased locomotor activity as well as sensitization of the major nociceptive neuron ASH, an arousal state that persists for 1--2 min. Both locomotor arousal and sensory facilitation require the release of FLP-20 neuropeptides from primary mechanosensory neurons, which act through the same Gα~q~-coupled receptor, FRPR-3. These effects involve FRPR-3-dependent activation of the neuroendocrine cell RID; thus, arousal appears to involve a chain of extrasynaptic signaling events acting in parallel to the circuitry of the wired connectome.

Results {#sec2}
=======

*C. elegans* Displays Both Locomotor and Sensory Arousal in Response to Aversive Stimuli {#sec2.1}
----------------------------------------------------------------------------------------

In many animals, behavioral arousal---including enhanced locomotor activity and facilitation of sensory pathways---often occurs following exposure to aversive stimuli. Indeed, we observed that non-localized mechanosensory stimulation (1× or 5× rapidly applied taps to the animal's Petri dish) led to a prolonged (up to 120 s) increase in forward locomotion speed ([Figure 1](#fig1){ref-type="fig"}A). To determine if this was a general effect of exposure to aversive stimuli, we applied various different stimuli, including heat, harsh touch, lifting with a platinum wire pick, and odorants, to wild-type animals and recorded their speed before and after stimulus application ([Figure S1](#mmc1){ref-type="supplementary-material"}A). As was the case for tap stimulation, animals showed a robust and persistent increase in locomotion speed in response to all the aversive stimuli, but not to benzaldehyde, which is an attractive stimulus ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Importantly, the effect of mechanosensory stimulation on locomotion was dose dependent, as increasing the number of taps led to a higher amplitude and longer-lasting period of locomotor arousal ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}B).Figure 1*C. elegans* Enters an Aroused Behavioral State in Response to Aversive Stimuli(A) Wild-type animals show an increased locomotion speed following the onset of mechanosensory (tap) stimuli. The acute effects of tap (\<10 s) are largely due to the initial escape response comprised of backward locomotion ([@bib65]). Five to ten animals were assayed in at least five trials for each condition.(B) Reversal distance for pre-aroused animals (1×tap or 5×tap) at various intervals prior to activation of ASH, compared with non-pre-aroused controls. Increased dosage of the pre-arousing stimulus extends the duration of the sensory sensitization effect. p values in black refer to comparisons between 1×tap and 5×tap. p values in blue or green refer to comparisons between 1×tap and no tap (blue) or 5×tap and no tap (green) for each duration tested. n \> 4 trials. Two-way ANOVA, Fisher's post-test: ns, not significant; ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001.(C) Reversal distance for aroused or unaroused *ASH::ChR2* animals in response to optogenetic activation of ASH 20 s after the pre-arousing tap stimulus. This interval was used for all subsequent experiments. n = 5 trials. Unpaired t test, ^∗∗∗∗^p \< 0.0001.(D) Mean traces of ASH calcium activity in response to glycerol either (i) alone or (ii) following a mechanical stimulus applied to the body of the animal.(E) Quantification of calcium activity in the ASH neuron. n = 8--25. Welch's t test, ^∗∗^p \< 0.01.For all panels, error bars indicate mean ± SEM. See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.

To determine if aroused animals also displayed increased sensory responsiveness, we investigated if behavioral responses to other aversive stimuli were enhanced during mechanically evoked arousal. We expressed the optogenetic actuator channelrhodopsin-2 (ChR2) cell-specifically in the ASH polymodal nociceptor neurons and tested whether the application of an arousing tap stimulus would lead to an enhanced escape response to ASH activation. Indeed, we found that animals receiving a tap stimulus prior to optogenetic activation of ASH exhibited a significantly higher reversal response compared with control animals that did not receive a pre-arousing stimulus ([Figures 1](#fig1){ref-type="fig"}B and 1C). Escape responses to repellents sensed by ASH, for example glycerol ([@bib32]), were likewise enhanced by prior experience of an arousing mechanical stimulus ([Figure S1](#mmc1){ref-type="supplementary-material"}D). Control animals in which ASH was not optogenetically activated showed reversal responses after tap that were not substantially different from unaroused animals ([Figure S1](#mmc1){ref-type="supplementary-material"}E), indicating that it was the aversive chemosensory pathway, rather than the reverse locomotor pathway per se, that was sensitized. As expected based on previous work ([@bib67]), tap stimulation did not significantly enhance the response to a second tap, indicating that sensitization of the ASH pathway is specific and cross-modal ([Figure S1](#mmc1){ref-type="supplementary-material"}F). Additionally, the presence of benzaldehyde, an appetitive stimulus, did not prevent enhancement of ASH responses by tap, although the magnitude of the enhancement was slightly though not significantly reduced ([Figure S1](#mmc1){ref-type="supplementary-material"}G). Similar to the effects on locomotor arousal, the dosage of the pre-arousing stimulus affected the duration of the sensory sensitization response, as multiple (5×) taps led to longer-lasting enhancement of ASH responses than a single tap ([Figure 1](#fig1){ref-type="fig"}B). Together, these results show that mechanosensory arousal not only increases locomotor activity but also sensitizes ASH-dependent sensory pathways linked to avoidance and escape behavior.

In principle, the enhanced escape behavior we observed in mechanically aroused animals could be the result of an increase in sensory neuron activity, or alternatively could result from downstream effects in the neural circuitry. To distinguish these possibilities, we directly measured ASH sensory responses in aroused and unaroused animals. We used genetically encoded calcium indicators to measure ASH calcium levels as a proxy for neuron activity after exposure to the osmotic stressor glycerol alone, or following mechanical stimulation of the anterior body. This experiment was performed using a custom microfluidics chip capable of providing both mechanical stimulation to the worm's anterior body using a pneumatic valve system and chemosensory stimulation to the head of the animal using off-chip solenoid valves ([@bib20], [@bib21]). Using this system, we found that animals pre-aroused with the mechanical stimulus demonstrated a significantly higher ASH calcium response to glycerol compared with animals that did not receive the pre-arousing stimulus ([Figures 1](#fig1){ref-type="fig"}D, 1E, and [S1](#mmc1){ref-type="supplementary-material"}H). Together with the finding that arousal enhances the behavioral response to optogenetic ASH stimulation, this result implies that mechanosensory stimulation increases the excitability of the ASH sensory neurons themselves, an effect we refer to as sensory facilitation. Interestingly, prior exposure to the aversive odorant nonanone, which can evoke locomotor arousal ([Figure S1](#mmc1){ref-type="supplementary-material"}A), did not significantly enhance ASH responses to glycerol ([Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B), nor did it enhance behavioral responses to optogenetic activation of ASH ([Figure S2](#mmc1){ref-type="supplementary-material"}C). Thus, ASH chemosensory responses appear to be enhanced specifically and cross-modally by body touch.

The Neuropeptide FLP-20 Is Required for Locomotor and Sensory Arousal {#sec2.2}
---------------------------------------------------------------------

We hypothesized that neuromodulators may be required for entry into the aroused behavioral state in *C. elegans* given the requirement for neuropeptides and neurotransmitters for arousal in other organisms. To identify *C. elegans* neuromodulators that are required for arousal, we performed a candidate screen for mutants that failed to increase their locomotion speed or exhibit sensory facilitation in response to an aversive tap stimulus ([Figure S3](#mmc1){ref-type="supplementary-material"}). We used an automated multiple worm tracker ([@bib63]) to measure locomotion speed of many (\>50--100) animals simultaneously in the minutes following mechanosensory stimulation. Using this method, we found that, compared with wild-type, animals carrying a deletion in the neuropeptide precursor gene *flp-20* showed a reduced magnitude of locomotor speed increase in response to tap ([Figures 2](#fig2){ref-type="fig"}A--2C and [S3](#mmc1){ref-type="supplementary-material"}B). However, *flp-20* mutants are able to sense mechanical stimulation, as they exhibited robust reversal behavior in response to gentle touch (which, like tap, is also sensed by the touch receptor neurons \[TRNs\]) that was not significantly different from wild-type ([Figure S2](#mmc1){ref-type="supplementary-material"}D). Thus, *flp-20* appears to be specifically required for locomotor arousal evoked by mechanosensory stimulation. We next tested if sensory facilitation also requires FLP-20. In the behavioral assay, we observed that *flp-20(ok2964)* deletion mutants, in contrast to control animals, failed to show robust mechanosensory enhancement of the reversal response to optogenetic activation of ASH ([Figures 2](#fig2){ref-type="fig"}D and [S3](#mmc1){ref-type="supplementary-material"}C). We also investigated if the increased ASH calcium responses to glycerol following pre-arousing mechanical stimulation required FLP-20. Again we found that *flp-20* mutant animals showed no significant enhancement of ASH chemosensory responses to glycerol by a prior mechanical arousing stimulus ([Figures 2](#fig2){ref-type="fig"}E and 2F). Taken together, these findings indicate that FLP-20 is required for both locomotor arousal and cross-modal sensitization following mechanical stimulation.Figure 2The Neuropeptide FLP-20 Is Required for Locomotor and Sensory Arousal(A--C) Locomotion arousal assays: (A) The speed of *flp-20* mutant animals compared with wild-type, following a tap stimulus, as shown in the speed trace indicating speed (μm/s) for 5 min. Tap stimulus is applied at t = 0. (B) shows a heatmap indicating the mean speed for all replicates. Only the first 60 s post-tap is shown. The red arrow indicates the time point at which the arousal speed is determined. (C) shows the quantification of arousal speed and the arousal integral. The diagram below shows how the arousal speed and arousal integral are calculated (see [STAR Methods](#sec4){ref-type="sec"} for details). Error bars indicate mean ± SEM. Unpaired t test: ^∗∗∗∗^p \< 0.0001. For (A)--(C), n \> 200 for at least three trials.(D--F) Cross-modal sensitization assays: (D) Reversal responses to blue light stimulation for wild-type and *flp-20* mutants expressing the *ASH::ChR2* transgene, with or without a pre-arousing tap. n = 5 trials. Unpaired t test: ^∗∗∗∗^p \< 0.0001. (E) Mean traces of ASH calcium activity in *flp-20* mutant animals measured with GCaMP3 in response to 0.5 M glycerol either (i) alone or (ii) following a mechanical stimulus applied to the body of the animal. n = 12--16. (F) Quantification of calcium activity in the ASH neuron of wild-type and *flp-20* mutant animals. Welch's t test: ns, not significant; ^∗^p \< 0.05. For (D)--(F), error bars indicate mean ± SEM. See also [Figures S2](#mmc1){ref-type="supplementary-material"} and [S3](#mmc1){ref-type="supplementary-material"}.

To determine where FLP-20 peptides are required for arousal, we assayed for phenotypic rescue under cell-type-specific promoters. We first generated a transgenic line expressing mKate2 under the control of the *flp-20* promoter (P*flp-20::flp-20 gDNA + 3ʹ UTR::SL2-mKate2*) to determine the expression pattern of *flp-20*. Consistent with previous findings ([@bib43]), we found that *flp-20* is expressed in the TRNs, along with a few other neurons (ASE, LUA, and PVC) ([Figure 3](#fig3){ref-type="fig"}A). Since the TRNs are known to be activated in response to tap stimuli, we next tested if re-expression of FLP-20 in the TRNs (using P*mec-4*) was able to rescue the defects observed in *flp-20* mutants. Indeed, this *TRN::flp-20* transgene was able to rescue locomotor arousal in *flp-20(ok2964)* mutant animals ([Figures 3](#fig3){ref-type="fig"}B--3D). Likewise, we observed that TRN-specific expression of *flp-20* rescued the cross-modal sensitization phenotype when measured either by behavioral response to optogenetic ASH activation ([Figure 3](#fig3){ref-type="fig"}E) or by calcium imaging of ASH chemosensory responses ([Figures 3](#fig3){ref-type="fig"}F and 3G). These results indicate that FLP-20 functions in the TRNs to promote multiple arousal pathways and imply that FLP-20 peptides are released directly from the TRNs following mechanical stimulation.Figure 3FLP-20 Neuropeptide Release from Touch Neurons Is Required for Arousal(A) A reporter line expressing the transgene *Pflp-20::flp-20 genomic DNA::SL2-mKate2* shows expression in the gentle touch neurons (TRNs: ALM, AVM, PLM, PVM) as well as ASE, LUA and PVC. Scale bar indicates 100 μm.(B--D) Locomotion arousal assays: (B) Expression of FLP-20 in the TRNs (P*mec-4*) in a *flp-20* mutant rescues the defect in locomotor arousal observed in *flp-20* mutant animals. (B) shows the speed trace for wild-type, *flp-20* mutants, and the TRN rescue line. The tap stimulus is applied at t = 0. (C) shows a heatmap indicating the mean speed for all replicates of each genotype tested. The red arrow indicates the time point at which the arousal speed is determined. (D) shows the quantification of arousal speed and the arousal integral after tap. n \> 200 for at least three trials. Error bars indicate mean ± SEM. One-way ANOVA, Sidak's post-test: ns, not significant; ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, ^∗∗∗∗^p \< 0.0001.(E--G) Cross-modal sensitization assays: (E) Reversal responses following blue light stimulation, with or without a pre-arousing tap, for wild-type, *flp-20* mutants, and rescue lines expressing FLP-20 using its own promoter (*flp-20::flp-20)* or using a TRN-specific promoter *mec-4* (*TRN::flp-20*). A control transgenic line re-expressing *flp-20* in ASE neurons (P*gcy-5*/P*gcy-7*) did not show significant rescue compared with *flp-20* mutants. One-way ANOVA, Sidak's post-test: ns, not significant, ^∗∗∗∗^p \< 0.0001. n = 3--6 trials. (F) Mean traces of ASH calcium activity in transgenic animals expressing *flp-20* in the TRNs after exposure to 0.5 M glycerol either (i) alone or (ii) following a mechanical stimulus applied to the body of the animal. n = 12--23. (G) Quantification of calcium activity in the ASH neuron for wild-type, *flp-20(ok2964)*, and *flp-20(ok2964);TRN::flp-20* animals. Welch's t test, ^∗^p \< 0.05, ^∗∗^p \< 0.01. For (E)--(G), error bars indicate mean ± SEM.

FRPR-3 Is a Receptor for FLP-20 Peptides that Mediates Arousal {#sec2.3}
--------------------------------------------------------------

To understand the neural mechanism by which *flp-20* triggers arousal, we first sought to identify the receptor for FLP-20 peptides. We expressed 79 candidate neuropeptide receptors from the *C. elegans* genome in mammalian cells expressing aequorin and the promiscuous G-protein Gα~16~, and assayed each for calcium responses to the peptides encoded by *flp-20*. We found that all three peptides encoded by the *flp-20* gene (AMMRFa, AVFRMa, SVFRLa) were able to activate one of these receptors, the FMRFamide-like peptide GPCR FRPR-3, with EC~50~ values in the low nanomolar range ([Figure 4](#fig4){ref-type="fig"}A). Interestingly, when *frpr-3* was expressed in cells expressing aequorin but lacking Gα~16~, each of the FLP-20 peptides still robustly evoked calcium transients, suggesting that FRPR-3 acts through a calcium-mobilizing second-messenger pathway such as Gα~q~/PLCβ ([Figure S4](#mmc1){ref-type="supplementary-material"}A). Phylogenetic analysis indicates that FRPR-3 belongs to the RFamide neuropeptide receptor family and is evolutionarily related to the *Drosophila* FMRFa receptor (Dmel\\FMRFaR) ([@bib26]).Figure 4The FLP-20 Receptor FRPR-3 Is Required for Locomotor Arousal(A) Dose-response curve showing that peptides encoded by the FLP-20 precursor activate the RFamide receptor FRPR-3 *in vitro*. The corresponding EC~50~ values for each peptide are as indicated. Line represents non-linear regression fit of a variable slope line using 4 parameters. n = 6--8 trials.(B--F) Locomotion arousal assays: (B) *frpr-3* deletion mutants show a smaller speed increase compared with wild-type following a tap stimulus, as shown in the speed trace. The tap stimulus is applied at t = 0. (C) Quantification of arousal speed indicating that *flp-20* and *frpr-3* single and double mutants are defective in locomotor arousal after tap. (D and E) The defect in tap arousal observed in single *frpr-3* and *flp-20* deletion mutant animals can be rescued by expression of FRPR-3 (*frpr-3(+)*) and FLP-20 (*flp-20(+)*) gDNA, respectively, under the control of the endogenous promoter for each gene. Double mutants of *flp-20* and *frpr-3* expressing the *flp-20(+)* transgene show decreased locomotor arousal after tap. (D) shows a heatmap indicating the mean speed for all replicates of each genotype tested. The red arrow indicates the time point at which the arousal speed is determined. (E) shows the quantification of arousal speed for all genotypes. (F) shows the quantification of the arousal integral. One-way ANOVA, Sidak's post-test: ns, not significant; ^∗^p \< 0.05, ^∗∗∗^p \< 0.001, ^∗∗∗∗^p \< 0.0001. Error bars indicate mean ± SEM. For (B)--(F), n \> 200 for at least three trials. See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

We next investigated whether the arousal phenotypes of *flp-20* depend on *frpr-3*. We obtained a deletion mutant of *frpr-3* and assayed it for locomotor and sensory arousal following mechanosensory stimulation. Similar to *flp-20(ok2964)* mutants, *frpr-3(ok3302)* mutant animals failed to significantly increase their speed in response to a tap stimulus ([Figures 4](#fig4){ref-type="fig"}B and 4C). Double-mutant animals containing both *flp-20* and *frpr-3* deletion alleles were arousal defective to a level similar to that of single mutants, suggesting that FRPR-3 and FLP-20 peptides act in the same pathway *in vivo* ([Figure 4](#fig4){ref-type="fig"}C). We were able to rescue locomotor arousal in *frpr-3* and *flp-20* mutants by re-expressing *frpr-3* and *flp-20*, respectively, under the control of the endogenous promoters for these genes ([Figures 4](#fig4){ref-type="fig"}D--4F and [S4](#mmc1){ref-type="supplementary-material"}B). We also found that the rescuing effect of the *flp-20(+)* transgene was dependent on FRPR-3, as *flp-20(+);flp-20(ok2964)* mutant animals also containing the *frpr-3(ok3302)* allele failed to increase their speed in response to tap ([Figures 4](#fig4){ref-type="fig"}D--4F). Together, these findings demonstrate that the effect of FLP-20 on arousal is FRPR-3 dependent, supporting the hypothesis that FRPR-3 is the receptor for FLP-20 peptides *in vivo* that mediates their effects on locomotor arousal.

We next tested if FRPR-3 was required to mediate other effects of FLP-20 peptides on behavior. Similar to our observations in *flp-20* mutant animals, we found that *frpr-3* mutants show a significantly reduced enhancement of the behavioral response to optogenetic ASH activation by an arousing tap stimulus ([Figure 5](#fig5){ref-type="fig"}A). Consistent with this effect on behavior, animals lacking *frpr-3* also did not show increased ASH neuron activity when stimulated with glycerol following a pre-arousing mechanical stimulus to the body ([Figures 5](#fig5){ref-type="fig"}B and 5C). In a previous study, we also showed that FLP-20 modulates responses to appetitive olfactory cues, leading to altered chemotaxis and an increased reversal rate off food in *flp-20* mutants ([@bib60]). This suggested that tonic FLP-20 signaling suppresses attractive responses. We observed that *frpr-3* mutants and *flp-20;frpr-3* double mutants exhibited this phenotype as well ([Figure S4](#mmc1){ref-type="supplementary-material"}C), consistent with FRPR-3 acting as the receptor for FLP-20 peptides in this behavior. Thus, FRPR-3 also appears to be the receptor that mediates other effects of FLP-20 peptides.Figure 5FRPR-3 Is Required for Sensory Sensitization(A) Reversal responses for wild-type and *frpr-3* mutants expressing the *ASH::ChR2* transgene following blue light stimulation, with or without a pre-arousing tap. n \> 8 trials. Unpaired t test, ^∗∗∗∗^p \< 0.0001.(B) Mean traces of ASH calcium activity in *frpr-3* mutant animals in response to 0.5 M glycerol either (i) alone or (ii) following a mechanical stimulus applied to the body of the animal, indicating a defect in sensory arousal in these mutant strains. n = 5--15.(C) Quantification of calcium activity in the ASH neuron of wild-type and *frpr-3* mutant animals. Welch's t test: ns, not significant; ^∗∗^p \< 0.01. Error bars indicate mean ± SEM. See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

FRPR-3 Acts in the RID Neuron for Locomotor Arousal and Cross-modal Sensitization {#sec2.4}
---------------------------------------------------------------------------------

We next investigated which FRPR-3-expressing cell(s) is required for arousal. We generated a transgenic line expressing mKate2 under the control of the *frpr-3* promoter (P*frpr-3::frpr-3 genomic DNA + 3ʹ UTR::SL2-mKate2*) to determine the expression pattern of this receptor. We found that FRPR-3 is expressed mainly in a few head neurons, including RID, ASK, AIY, and AVK, consistent with previous expression data ([@bib75]) ([Figure 6](#fig6){ref-type="fig"}A). We were intrigued by FRPR-3 expression in RID, as this interneuron was recently shown to be required for sustaining the forward motor state ([@bib49]). As of yet, no RID-specific promoter has been identified. To determine if FRPR-3 in RID is required for tap arousal, we tested if expressing a transgene for *frpr-3* using three different promoters driving expression in RID as well as other neurons could rescue the defect in locomotor arousal observed in *frpr-3* mutant animals. Indeed, we found that expression of FRPR-3 using either the *flp-2* ([@bib43]), *des-2* ([@bib77]), or *ceh-10* promoter ([@bib3], [@bib49]) all showed significantly increased speed induced by tap compared with *frpr-3* mutant animals ([Figures 6](#fig6){ref-type="fig"}B--6D and [S5](#mmc1){ref-type="supplementary-material"}A). We also found that re-expression of *frpr-3* in AIY (using P*ttx-3*) was able to significantly rescue the defect in locomotor arousal observed in *frpr-3* mutants ([Figures S5](#mmc1){ref-type="supplementary-material"}A--S5C). In contrast, a transgene expressing *frpr-3* in the AVK (using P*flp-1*) or ASK neurons (using P*sra-9*) failed to rescue the locomotor arousal defect ([Figures 6](#fig6){ref-type="fig"}B--6D and [S5](#mmc1){ref-type="supplementary-material"}A--S5C).Figure 6FRPR-3 Acts in the RID Neuron for Locomotor Arousal and Sensory Sensitization(A) A reporter line expressing the transgene *Pfrpr-3::frpr-3 genomic DNA::SL2-mKate2* shows expression mostly in head neurons including RID, ASK, AIY, and AVK. Scale bar indicates 10 μm.(B--D) Locomotion arousal assays: Re-expression of *frpr-3* in RID (and other neurons) using the *flp-2*, *des-2*, and *ceh-10* promoters rescued the defect in tap arousal in *frpr-3* mutants, whereas transgenic re-expression of *frpr-3* in AVK using the *flp-1* promoter failed to show significant rescue. (B) shows the speed trace for all genotypes. The tap stimulus is applied at t = 0. (C) shows a heatmap indicating the mean speed for all replicates of each genotype tested. The tap stimulus is applied at t = 0. The red arrow indicates the time point at which the arousal speed is determined. (D) shows the quantification of arousal speed and the arousal integral after tap. n \> 200 for at least three trials. For (B) and (D), error bars indicate mean ± SEM. One-way ANOVA, Sidak's post-test: ns, not significant; ^∗∗∗∗^p \< 0.0001.(E--G) Cross-modal sensitization assays: (E) Reversal responses for wild-type and *RID(RNAi)::frpr-3* animals following blue light stimulation, with or without a pre-arousing tap. RNAi transgenes were expressed using P*flp-2* and P*des-2*. Two-way ANOVA, Fisher's post-test: ns, not significant; ^∗∗^p \< 0.01. n \> 6 trials. (F) Mean traces of ASH calcium activity in *frpr-3(ok3302);RID(Pdes-2)::frpr-3* transgenic animals in response to glycerol either (i) alone or (ii) following a mechanical stimulus applied to the body of the animal. n = 12--25. (G) Quantification of calcium activity in the ASH neuron for wild-type, *frpr-3(ok3302)*, *frpr-3(ok3302);RID(Pdes-2)::frpr-3*, and *frpr-3(ok3302);RID(Pflp-2)::frpr-3* transgenic animals. For (E)--(G), error bars indicate mean ± SEM. Welch's t test, ^∗^p \< 0.05, ^∗∗^p \< 0.01. See also [Figures S5](#mmc1){ref-type="supplementary-material"} and [S6](#mmc1){ref-type="supplementary-material"}.

We also investigated where *frpr-3* was required for cross-modal sensitization. To address this question, we knocked down *frpr-3* expression in different *frpr-3*-expressing neurons using cell-specific RNAi. We knocked down expression in RID by expressing antisense and sense sequences of *frpr-3* with a promoter combination (P*flp-2* and P*des-2*) that overlap in RID. We found that knockdown of *frpr-3* in RID using this intersectional promoter strategy led to a significant decrease in ASH-driven reversal responses following a pre-arousing tap stimulus ([Figures 6](#fig6){ref-type="fig"}E and [S6](#mmc1){ref-type="supplementary-material"}B). We also tested knockdown of *frpr-3* using other promoter combinations that appear to solely overlap in RID ([Figures S6](#mmc1){ref-type="supplementary-material"}A and S6B). Knockdown of *frpr-3* in two of these three additional lines showed a significant decrease in ASH sensitization compared with controls ([Figure S6](#mmc1){ref-type="supplementary-material"}B). In contrast, knockdown of *frpr-3* in ASK, which is connected by gap junctions to ASH, or in ASH itself, had no significant effect on sensory sensitization ([Figure S5](#mmc1){ref-type="supplementary-material"}D). Consistent with these behavioral results, we found that transgenic re-expression of FRPR-3 in RID using both the *des-2* and *flp-2* promoters ([Figures 6](#fig6){ref-type="fig"}F, 6G, and [S5](#mmc1){ref-type="supplementary-material"}E) conferred significant rescue of the ASH sensitization phenotype as measured by calcium imaging of ASH chemosensory responses. Interestingly, although AIY expression of *frpr-3* appears to modulate locomotor arousal ([Figures S5](#mmc1){ref-type="supplementary-material"}A--S5C), knockdown of *frpr-3* in AIY had no effect on cross-modal sensitization ([Figure S5](#mmc1){ref-type="supplementary-material"}F). Additionally, knockdown of *frpr-3* in AVK, in which *frpr-3* is strongly expressed ([Figure 6](#fig6){ref-type="fig"}A), had no effect on ASH sensory responses ([Figure S5](#mmc1){ref-type="supplementary-material"}F). Altogether, our data are consistent with FRPR-3 mediating the effects of FLP-20 peptides on both locomotor and sensory arousal through its effects on the RID neuron.

FLP-20 and FRPR-3 Facilitate Enhanced RID Activity in Response to Mechanical Stimuli {#sec2.5}
------------------------------------------------------------------------------------

To further investigate the role of the RID neuron in tap-mediated arousal, we recorded neuronal activity in RID in response to mechanical stimulation. We applied a computer-controlled mechanosensory stimulus to the posterior half of the body to activate the TRNs and simultaneously measured RID calcium responses using the sensor Cameleon (YC3.60). In wild-type animals, there was a robust increase in calcium transients in RID in response to mechanical stimulation ([Figure 7](#fig7){ref-type="fig"}A). In contrast, this response was significantly diminished in *frpr-3* mutants and was almost completely abolished in *flp-20* mutant animals ([Figures 7](#fig7){ref-type="fig"}A and 7B). We found that wild-type animals showed positive responses as determined by the observation of calcium transients in 79.% ± 1.0% (mean ± SEM) of stimulations, whereas *frpr-3* and *flp-20* mutants showed 38.2% ± 4.3% and 11.2% ± 1.8% positive responses, respectively ([Figure 7](#fig7){ref-type="fig"}C). Consistent with the requirement for FRPR-3 in RID for locomotor arousal behavior, we could rescue the defective RID neural activity in *frpr-3* mutants by re-expressing *frpr-3* in RID and in *flp-20* mutants by re-expressing *flp-20* in the TRNs ([Figures 7](#fig7){ref-type="fig"}B, 7C, and [S7](#mmc1){ref-type="supplementary-material"}A). Cell-specific transgenic re-expression of these genes could also rescue the proportion of neurons responding to mechanical stimulation to 83.1% ± 4.8% in *frpr-3(ok3302);RID::frpr-3* animals and 76.4% ± 5.8% in *flp-20(ok2964);TRN::flp-20* transgenic animals ([Figure 7](#fig7){ref-type="fig"}C). These data are consistent with FLP-20 peptides released from the TRNs being required for arousal by activating FRPR-3 receptors in RID.Figure 7FLP-20/FRPR-3 Facilitates Enhancement of RID Activity in Response to Mechanical Stimuli(A) Mean calcium traces for wild-type and *flp-20* or *frpr-3* mutant animals in RID following mechanosensory stimulation. The maximum ratio change is shown as mean ± SEM for each trace. The number of worms tested is shown, with each worm stimulated one to three times. Scale shows % ratio change on the y axis and time (s) on the x axis.(B) Quantification of calcium activity in the ASH neuron plotted as the maximum ratio of YFP/CFP as a percentage of the baseline YFP/CFP ratio. Welch's t test: ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗∗^p \< 0.0001. n (traces) = 38--65.(C) Proportion of trials showing a positive response to mechanical stimulation based on the observation of calcium transients in RID. One-way ANOVA, Fisher's post-test: ^∗∗∗∗^p \< 0.0001.(D) Optogenetic activation of RID with red light prior to activation of ASH using blue light leads to an increased reversal distance compared with animals stimulated with blue light alone. As a positive control, animals of the same genotype were provided with a tap stimulus prior to ASH activation. n = 5 trials.(E) Reversal responses for wild-type, *RID(RNAi)::unc-31* and animals following blue light stimulation, with or without a pre-arousing tap. Two-way ANOVA, Fisher's post-test: ^∗∗^p \< 0.01.(F) (i) Speed traces and (ii) arousal integral for *RID(RNAi)::unc-31* and control animals after a 1x tap stimulus at t = 0. For (E) and (F), RNAi transgenes were expressed using P *flp-2* and P*des-2*. Unpaired t test: ^∗∗^p \< 0.01. n \> 6 trials. Error bars indicate mean ± SEM.(G) In response to mechanical stimulation, FLP-20 is released from the mechanosensory TRNs and drives behavioral arousal via its receptor FRPR-3 acting primarily in RID. FLP-20/FRPR-3 signaling sensitizes the ASH neuron, at least partially via neuropeptides. FLP-20-dependent activation of FRPR-3 in RID enhances locomotion through peptide neuromodulation and perhaps synaptic and/or gap-junction signaling. Mechanosensory neurons also trigger escape behavior through wired connections to premotor interneurons. See also [Figure S7](#mmc1){ref-type="supplementary-material"}.

Is activation of RID sufficient for arousal? A previous study demonstrated that optogenetic activation of RID using Chrimson was sufficient to potentiate the speed of forward locomotion ([@bib49]), thus mimicking the effect of locomotor arousal. To determine whether RID activation is also sufficient to facilitate ASH-mediated escape behavior, we crossed the *RID::Chrimson* transgenic line from the ([@bib49]) study with our *ASH::ChR2* transgenic line and tested whether prior optogenetic activation of RID could enhance the response to ASH activation. We indeed observed significant sensitization of ASH-mediated escape behavior in this assay, suggesting that increased RID activity could account for both aspects of FLP-20-mediated mechanosensory arousal ([Figure 7](#fig7){ref-type="fig"}D).

RID is a specialized neuroendocrine cell ([@bib49]) that contains no known classical neurotransmitters or monoamines ([@bib55]); however, it expresses a number of neuropeptides ([@bib40], [@bib43], [@bib49]) as well as making gap junctions with a number of interneurons ([@bib81]). We therefore hypothesized that RID activity might promote ASH sensitization and locomotor arousal through release of peptide neuromodulators. As a first step to investigate this possibility, we used RNAi to selectively knock down *unc-31*, a CAPS protein specifically required for dense core vesicle release ([@bib71]), in the RID neuron. We observed that these *RID(RNAi)::unc-31* animals indeed showed significant defects in both ASH sensitization ([Figure 7](#fig7){ref-type="fig"}E) and locomotor arousal ([Figure 7](#fig7){ref-type="fig"}F) in response to mechanosensory stimulation. Interestingly, RID-specific knockdown of *egl-21*, which encodes an enzyme required for maturation of many *C. elegans* neuropeptides ([@bib39]), did not significantly affect ASH sensitization ([Figure S7](#mmc1){ref-type="supplementary-material"}B) but resulted in a small yet significant reduction in locomotor arousal ([Figure S7](#mmc1){ref-type="supplementary-material"}C). Thus, RID may use EGL-21-independent neuropeptides ([@bib36], [@bib76]) to modulate peripheral sensory targets during arousal whereas EGL-21-processed neuropeptides may play a larger role in signaling to downstream motor circuits.

Discussion {#sec3}
==========

We have described a novel paradigm for behavioral arousal in *C. elegans* and have characterized key aspects of its neural and molecular mechanism. Mechanosensory stimulation leads to an increase in locomotor speed that persists for minutes, as well as cross-modal sensitization of nociceptor neurons on a similar timescale. Both locomotor and sensory arousal behaviors require FLP-20 neuropeptides, released directly from primary mechanosensory neurons, and their receptor FRPR-3. FRPR-3 in turn modulates the activity of the neuroendocrine cell RID, which becomes activated in response to mechanical stimulation in a FLP-20 and FRPR-3-dependent manner ([Figure 7](#fig7){ref-type="fig"}G). RID activation is sufficient for both locomotor arousal and cross-modal sensitization, and both processes depend at least in part on dense core vesicle release from RID. Thus, tap-evoked arousal may involve a cascade of neuropeptide signaling, with FLP-20 conveying mechanosensory information from sensory neurons to RID, and efferent neuromodulators conveying behavioral state information from RID to peripheral sensory and motor circuits.

The cellular mechanisms underlying sensitization have been studied for several decades, beginning with work in *Aplysia* ([@bib12]) and more recently in genetically-tractable organisms such as *C. elegans* ([@bib5], [@bib17], [@bib23]), but important questions remain. First, does sensitization involve effects on the sensory organ itself, or in the integration and gating of sensory signals? Studies in *Drosophila* suggest that some of the changes in sensory sensitivity during normally quiescent periods may be due to the activity of "clock" neurons that regulate circadian rhythms rather than direct effects on sensory neurons ([@bib78]). Our findings suggest that, in the case of FLP-20 and FRPR-3, changes in responsiveness to an aversive chemical following arousal result from increased sensitivity of the sensory neuron ASH itself and not in downstream components of the circuit. Second, during arousal, is sensitization restricted to particular sensory modalities or is there a generalized state of increased sensory responsiveness? In zebrafish, increasing orexin/hypocretin levels specifically affect responsiveness to dark-flash visual stimuli, but not to acoustic or thermal stimuli ([@bib83]). In another study, arousal induced by water-flow leads to elevated locomotion and increased sensitivity to visual motion but not light-flash or acoustic stimuli ([@bib84]). These studies suggest that arousal in response to a particular stimulus results in increased responsiveness to only particular "goal-directed" sensory modalities. This also appears to be the case for FLP-20-dependent modulation (see below).

Although this study is the first to describe a cellular mechanism for arousal in response to an acute noxious stimulus, the influence of a stressful environment (for example, starvation) on sensitization and/or locomotor arousal has been described in other contexts. For example, the neurotransmitters dopamine ([@bib27], [@bib28]) and serotonin ([@bib16], [@bib31]) act through multiple receptors to enhance ASH chemical avoidance responses in the presence of food. This is analogous to observations in mammals where satiety or hunger also alters the sensory responsiveness to olfactory cues ([@bib1], [@bib62]). Wild *C. elegans* strains also show increased locomotor activity in the presence of high oxygen ([@bib44]); although the trigger for this arousal is not well understood, a neuropeptide signaling pathway involving the NPR-1 receptor and the FLP-18 and FLP-21 peptides has been shown to negatively regulate this response ([@bib29], [@bib66]). Heightened locomotor activity in unfavorable conditions has also been observed in zebrafish ([@bib24], [@bib58]) and flies ([@bib45]).

For both locomotor arousal and cross-modal sensitization, a critical cellular site of FLP-20/FRPR-3 signaling is the RID neuron ([Figures 6](#fig6){ref-type="fig"} and [7](#fig7){ref-type="fig"}). RID becomes activated in response to mechanosensory stimuli in a FLP-20 and FRPR-3 dependent manner ([Figure 7](#fig7){ref-type="fig"}), and cell-specific rescue and/or knockdown experiments identify RID as a focus of both the locomotor arousal and sensitization phenotypes of *frpr-3*. We also found that optogenetically activating RID is sufficient for cross-modal sensitization of ASH ([Figure 7](#fig7){ref-type="fig"}D). Interestingly, although loss of *flp-20* completely eliminated RID responses to body touch, detectable RID touch responses remained in the *frpr-3* mutant ([Figures 7](#fig7){ref-type="fig"}A and 7B); thus, some FLP-20-mediated effects on RID may be independent of FRPR-3. In our study, FRPR-3 was the only high-potency receptor identified, but the possibility remains that FLP-20 peptides activate other, as-yet-unidentified receptors. Moreover, we cannot rule out the possibility that other cells may represent biologically relevant targets of FLP-20 signaling during arousal. In particular, we found that *frpr-3* expression in AIY affected locomotor arousal ([Figures S5](#mmc1){ref-type="supplementary-material"}A--S5C), though not cross-modal sensitization of ASH ([Figure S5](#mmc1){ref-type="supplementary-material"}F). AIY has previously been shown to promote increased locomotion speed via excitatory synapses with RIB ([@bib48]), as well as through gap junctions with RIM ([@bib30]). Interestingly, RIM controls locomotion at least in part through release of tyramine ([@bib2], [@bib25], [@bib57]), and our initial candidate screen identified the tyramine receptors SER-2 and TYRA-2 as potential modulators of tap-evoked locomotor arousal ([Figure S3](#mmc1){ref-type="supplementary-material"}B), but not cross-modal sensitization ([Figure S3](#mmc1){ref-type="supplementary-material"}C).

RID is one of a small number of *C. elegans* neurons that express no classical neurotransmitter or monoamine ([@bib55]), implying that they may be specialized for neuroendocrine function. While most *C. elegans* neurons contain modest numbers of dense core vesicles, generally peripheral to chemical synapses, RID signals predominantly through large varicosities that contain almost exclusively dense core vesicles ([@bib49]). Both transgenic reporter and expression profiling studies reveal expression of multiple neuropeptide precursor genes in RID ([@bib40], [@bib43], [@bib49]), including several previously linked to locomotor arousal ([@bib18]). RID makes a few chemical and electrical synapses with motorneurons and body muscle, but much of its effect on locomotion appears to be through neuroendocrine actions on the somatic neuromusculature ([@bib49], [@bib81]). Likewise, RID and ASH neurons are not physically connected via synapses or gap junctions, suggesting that communication between RID and ASH could occur most directly via extrasynaptic neuromodulation. We have shown here that *unc-31* knockdown in RID significantly reduces ASH sensitization in response to tap ([Figure 7](#fig7){ref-type="fig"}E), indicating that cross-modal sensitization involves the release of neuromodulators from dense core vesicles in RID. Perhaps surprisingly, RID knockdown of *egl-21*, which encodes an enzyme required for processing many *C. elegans* neuropeptides ([@bib39]), did not significantly affect ASH sensitization ([Figure S7](#mmc1){ref-type="supplementary-material"}B), although it did affect locomotor arousal ([Figure S7](#mmc1){ref-type="supplementary-material"}C). Mass spectrometry analysis of *egl-21* mutants indicates that a significant number of *C. elegans* neuropeptides do not require EGL-21 for their processing ([@bib36]). These peptides may be processed by two other putative carboxypeptidases, *cpd-1* and *cpd-2*, which have not been comprehensively characterized ([@bib39], [@bib46]).

While RID-released peptides seem to promote arousal in a variety of contexts, FLP-20 peptides released from the TRNs appear to specifically encode mechanosensory information. We have shown here that strong acute activation of the TRNs leads to transient FLP-20/FRPR-3-dependent modulation of RID, which in turn promotes locomotor arousal and sensitization of aversive chemosensation. In contrast, our previous work showed that tonic FLP-20 signaling from the TRNs inhibits the acuity of attractive olfactory pathways via suppression of the interneuron AIY's responses to the odorant benzaldehyde. Consequently, in touch-insensitive mutants where this tonic mechanosensory activity was lost, olfactory acuity was sensitized due to a loss of FLP-20 signaling ([@bib60]). We showed in this study that this effect was also dependent on FRPR-3 ([Figure S4](#mmc1){ref-type="supplementary-material"}C). Similarly, intermediate-term memory of tap habituation following massed training has been shown to require FLP-20 peptides released from the TRNs ([@bib47]). This indicates that FLP-20 signaling acts to inhibit or stabilize the inhibition of mechanosensory responsiveness. Thus, the role of FLP-20 in modulating different sensory modalities appears to depend on context; for aversive chemosensation, FLP-20 peptides enhance sensitivity during acute touch-evoked arousal, whereas for appetitive chemosensation or gentle body touch itself, they diminish sensitivity in response to tonic or prolonged mechanosensory activity. FLP-20 peptides therefore do not function as generalized arousal signals, leading to a general increase in sensory responsiveness, but rather provide mechanosensory information to central neurons on a neuromodulatory timescale. Hence, FLP-20 peptides can be considered afferent neuromodulators that convey sensory information rather than efferent modulators that control peripheral targets.

We have shown that arousal following touch stimulation may involve a sequence of extrasynaptic neuromodulatory signals beginning with a FLP-20/FRPR-3-mediated signal conveying mechanosensory activity to RID. A signal involving multiple arousal neuropeptides released from RID has previously been shown to promote enhanced locomotor activity ([@bib18], [@bib49]), consistent with data from our study showing that RID peptides are required for both locomotor and sensory arousal ([Figures 7](#fig7){ref-type="fig"}E and 7F). This wireless pathway complements the reflexive escape response involving wired synapses and gap junctions between mechanosensory neurons, premotor interneurons and motorneurons leading to reversals ([@bib14]) ([Figure 7](#fig7){ref-type="fig"}G). In contrast to the reversal response that is triggered instantaneously and persists for several seconds, the arousal response results in prolonged motor hyperactivity over a timescale of minutes. Moreover, while the arousal response depends on the release of FLP-20 peptides from the touch receptor neurons, reversals depend on coupling of sensory neurons to interneurons ([@bib14], [@bib53]) via chemical synapses, which are glutamatergic in the TRNs ([@bib70]), and gap junctions. In addition, the glutamate transporter *eat-4* is required for normal responses to repeated taps ([@bib64]), and the glutamate receptor *glr-1* is required for long-term memory for habituation to tap responses ([@bib68]). Thus, co-transmission of glutamate and FLP-20 peptides by the mechanosensory TRNs may provide a means for the animal to alter locomotor activity in multiple ways and on multiple timescales. Another interesting example of co-transmission in *C. elegans* is the release of glutamate and NLP-1 neuropeptides from the sensory neuron AWC, where each neuromodulator has distinct effects on local search and responsiveness toward olfactory cues ([@bib13]). Likewise, mouse neurons that release the arousal peptide orexin/hypocretin also release glutamate, which may serve to deliver complementary signals associated with firing of these neurons to downstream effectors of arousal ([@bib69]). Thus, cotransmission represents a mechanism by which the animal can stabilize and consolidate important behavioral states, or respond to sensory cues of varying magnitudes and on different timescales (reviewed in [@bib11], [@bib50], [@bib52]).

The nervous system of *C. elegans*, although relatively compact, shows surprising complexity within the connectome and in its repertoire of behavioral outputs ([@bib79]). Its complement of neuropeptides and receptors is diverse and shows conservation with many other animals, including humans ([@bib41], [@bib54]). Neuromodulators may tune signaling through the wired circuitry by promoting particular connections over others and could also increase the potential for plasticity ([@bib8], [@bib52]). Future work could exploit this system as a model to understand the principles through which neuropeptide signaling networks interact with the synaptic connectome to control behavioral states.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Bacterial and Virus Strains***E. coli*: Strain OP50*Caenorhabditis* Genetics Center (CGC)WormBase: OP50**Chemicals, Peptides, and Recombinant Proteins**AMMRFa, AVFRMa, SVFRLaGL Biochem (Shangai)N/A**Experimental Models: Cell Lines**CHO-K1 cell linePerkinElmerES-000-A2**Experimental Models: Organisms/Strains***C. elegans:* Strain AQ4045 *ljEx1107\[Psra-6::GCaMP3::SL2-tagRFP(50);unc-122::RFP(50)\]*This studyN/A*C. elegans:* Strain AQ4076 *flp-20(ok2964);ljEx1107*This studyN/A*C. elegans:* Strain AQ4077 *frpr-3(ok3302);ljEx1107*This studyN/A*C. elegans:* Strain AQ4168 *frpr-3(ok3302);ljEx1149\[Pdes-2::frpr-3cDNA::gpd-2 3′ UTR(pYLC219)(25);unc-122::gfp(50)\];ljEx1107*This studyN/A*C. elegans:* Strain AQ4169 *frpr-3(ok3302);ljEx1150\[Pflp-2::frpr-3cDNA::gpd-2 3′ UTR(pYLC220)(25);unc-122::gfp(50)\];ljEx1107*This studyN/A*C. elegans:* Strain AQ4173 *flp-20(ok2964);ljEx1094\[Pmec-4::flp-20 gDNA + 3′ UTR::SL2-mKate2 (50);unc-122::gfp(50)\];ljEx1107*This studyN/A*C. elegans:* Strain AQ2052 *lite-1(ce314);ljIs105\[sra-6::ChR2::yfp, unc-122::gfp\]*This studyN/A*C. elegans:* Strain AQ2235 *lite-1(ce314); ljIs114\[Pgpa-13::FLPase, Psra-6::FTF::ChR2::YFP\] X*This studyN/A*C. elegans:* Strain AQ2755 *lite-1(ce314); ljIs124\[Pgpa-13::FLPase, Psra-6::FTF::ChR2::YFP\]not X*This studyN/A*C. elegans:* Strain VG266 *frpr-3(gk240031) (backcrossed 3x); lite-1(ce314); ljIs114*This studyN/A*C. elegans:* Strain AQ2786 *flp-20 (ok2964) lite-1(ce314) X; ljIs124*This studyN/A*C. elegans:* Strain AQ3941 *lite-1(ce314) flp-20(ok2964)X; ljIs124; Ex\[Pmec-4::flp-20 cDNA)(20);unc-122::gfp(20)\]* line-1This studyN/A*C. elegans:* Strain AQ3940 *lite-1(ce314) flp-20(ok2964)X; ljIs124; Ex\[Pflp-20::flp-20 cDNA (20), ccGFP (20)\]* line-1This studyN/A*C. elegans:* Strain AQ4246 *lite-1(ce314) flp-20(ok2964)X; ljIs124; Ex\[Pflp-20::flp-20 cDNA (20), ccGFP (20)\]* line-2This studyN/A*C. elegans:* Strain AQ4247 *lite-1(ce314) flp-20(ok2964)X; ljIs124; Ex\[Pflp-20::flp-20 cDNA (20), ccGFP (20)\]* line-3This studyN/A*C. elegans:* Strain AQ4248 *lite-1(ce314) flp-20(ok2964)X; ljIs124; Ex\[Pmec-4::flp-20 cDNA)(20);unc-122::gfp(20)\]* line-2This studyN/A*C. elegans:* Strain AQ4249 *lite-1(ce314) flp-20(ok2964)X; ljIs124; Ex\[Pmec-4::flp-20 cDNA)(20);unc-122::gfp(20)\]* line-3This studyN/A*C. elegans:* Strain AQ4250 *lite-1(ce314) flp-20(ok2964)X; ljIs124; Ex\[Pgcy-5::flp-20(10); Pgcy-7::flp-20(10);unc-122::gfp(20)\]* line-1This studyN/A*C. elegans:* Strain AQ4251 *lite-1(ce314) flp-20(ok2964)X; ljIs124; Ex\[Pgcy-5::flp-20(10); Pgcy-7::flp-20(10);unc-122::gfp(20)\]* line-2This studyN/A*C. elegans:* Strain AQ4252 *lite-1(ce314) flp-20(ok2964)X; ljIs124; Ex\[Pgcy-5::flp-20(10); Pgcy-7::flp-20(10);unc-122::gfp(20)\]* line-3This studyN/A*C. elegans:* Strain AQ4260 *lite-1(ce314);ljIs124;ljEx1187\[Psra-6::frpr-3 antisense RNAi(50);Psra-6::frpr-3 sense RNAi(50);ccGFP(30)\]*This studyN/A*C. elegans:* Strain AQ4262 *lite-1(ce314);ljIs124;ljEx1189\[Psra-9::frpr-3 antisense RNAi(55);Psra-9::frpr-3 sense RNAi(55);ccGFP(30)\]*This studyN/A*C. elegans:* Strain AQ4264 *lite-1(ce314);ljIs124;ljEx1191\[Pflp-2::frpr-3 antisense RNAi(50);Pdes-2::frpr-3 sense RNAi(50);ccGFP(30)\]*This studyN/A*C. elegans:* Strain AQ4320 *lite-1(ce314);ljIs124;ljEx1214\[Pdes-2::egl-21 antisense RNAi(50);Pflp-2::egl-21 sense RNAi(50);ccGFP(40)\]*This studyN/A*C. elegans:* Strain AQ4346 *lite-1(ce314);ljIs124;ljEx1228\[Pflp-2::frpr-3 antisense RNAi(50);Pceh-10(3.6)::frpr-3 sense RNAi(50);ccGFP(50)\]*This studyN/A*C. elegans:* Strain AQ4355 *lite-1(ce314);ljIs124;ljEx1229\[Pdes-2::frpr-3 antisense RNAi(50);Pceh-10(3.6)::frpr-3 sense RNAi(50);ccGFP(50)\]*This studyN/A*C. elegans:* Strain AQ4356 *lite-1(ce314);ljIs124;ljEx1230\[Pins-17(2kb)::frpr-3 antisense RNAi(50);Pceh-10(3.6)::frpr-3 sense RNAi(50);ccGFP(50)\]*This studyN/A*C. elegans:* Strain AQ4360 *lite-1(ce314);ljIs124;ljEx1234\[Pflp-2::unc-31 antisense RNAi(50);Pdes-2::unc-31 sense RNAi(50);ccGFP(50))\]*This studyN/A*C. elegans:* Strain AQ4364 *lite-1(ce314);ljIs124;ljEx1238\[Pttx-3::frpr-3 antisense RNAi(50);Pttx-3::frpr-3 sense RNAi(50);unc-122::gfp(50)\]*This studyN/A*C. elegans:* Strain AQ4365 *lite-1(ce314);ljIs124;ljEx1239\[Pflp-1::frpr-3 antisense RNAi(50);Pflp-1::frpr-3 sense RNAi(50);unc-122::gfp(50)\]*This studyN/A*C. elegans:* Strain AQ4390 *lite-1(ce314);ljIs124;hpIs626(Pceh10::Chrimson::GFP::ZF; Pttx-3::ZIF-1::SL2::RFP; Pgpa-14::ZIF-1::SL2::RFP);hpEx3808(Parr-1-ZIF-1::SL2::RFP;Pmyo-3::rfp)*This studyN/A*C. elegans:* Strain AQ4023 ljEx1093\[Pflp-20::flp-20 gDNA + 3′ UTR::SL2-mKate2(50);unc-122::gfp(50)\]This studyN/A*C. elegans:* Strain AQ4006 *ljEx1090\[Pfrpr-3::frpr-3 gDNA::SL2-mKate(25); unc-122::gfp(50)\]*This studyN/A*C. elegans:* Strain TU253 mec-4(u253) XCGCWormbase: TU253*C. elegans:* Strain AQ4019 *frpr-3(ok3302);ljEx1090*This studyN/A*C. elegans:* Strain AQ4035 *flp-20(ok2964);ljEx1094*This studyN/A*C. elegans:* Strain AQ4037 *flp-20(ok2964);ljEx1093*This studyN/A*C. elegans:* Strain AQ4054 *frpr-3(ok3302);flp-20(ok2964)*This studyN/A*C. elegans:* Strain AQ4072 *flp-20(ok2964);frpr-3(ok3302);ljEx1093*This studyN/A*C. elegans:* Strain AQ4078 *frpr-3(ok3302);ljEx1108\[Pflp-1::frpr-3 gDNA + UTR(10);unc-122::GFP(50)\]*This studyN/A*C. elegans:* Strain AQ4104 *frpr-3(ok3302);ljEx1135\[Pflp-2::frpr-3::SL2-mKate2 (50);unc-122::gfp(50)\]*This studyN/A*C. elegans:* Strain AQ4105 *frpr-3(ok3302);ljEx1136\[Pdes-2::frpr-3::SL2-mKate2 (50);unc-122::gfp(50)\]*This studyN/A*C. elegans:* Strain AQ4179 *frpr-3(ok3302);ljEx1167\[Pceh-10(3.6)::frpr-3::SL2-mKate2(pYLC232)(50);unc-122::gfp(50)\]*This studyN/A*C. elegans:* Strain AQ4087 *frpr-3(ok3302);ljEx1123\[Psra-9::frpr-3 gDNA + 3′ UTR::SL2-mKate2(50);ccGFP(50)\]*This studyN/A*C. elegans:* Strain AQ4103 *frpr-3(ok3302);ljEx1134\[Pttx-3::frpr-3::SL2-mKate2 (50)(pYLC190);ccGFP(50)\]*This studyN/A*C. elegans:* Strain AQ3832 *frpr-3(ok3302) V* backcrossed 6xThis studyN/A*C. elegans:* Strain AQ4000 *flp-20(ok2964) X* backcrossed 6xThis studyN/A*C. elegans:* Strain AQ4396 *ljEx1246\[Pdes-2::mKate2::gpd-2 3′ UTR(25);ccGFP(50)\];ljEx1247\[Pflp-2:gfp::gpd-2 3′ UTR(25);ccRFP(50)\]*This studyN/A*C. elegans:* Strain AQ4397 *ljEx1246\[Pdes-2::mKate2::gpd-2 3′ UTR(25);ccGFP(50)\];ljEx1165\[Pceh-10(3.6)::YC3.60::gpd-2 3′ UTR(25);ccRFP(50)\]*This studyN/A*C. elegans:* Strain AQ4398 *unc-119(ed3) III; wwEx73(ins-17p::gfp + unc-119(+));ljEx1167\[Pceh-10(3.6)::frpr-3::SL2-mKate2(50);ccGFP(50)\]*This studyN/A*C. elegans:* Strain AQ4399 *ljEx1167\[Pceh-10(3.6)::frpr-3::SL2-mKate2(50);ccGFP(50)\];ljEx1247\[Pflp-2:gfp::gpd-2 3′ UTR(50);ccRFP(50)\]*This studyN/A*C. elegans:* Strain PT505 *flp-20(pk1596) X*CGCWormbase: PT505*C. elegans:* Strain VC2565 *frpr-3(ok3302) V*CGCWormbase: VC2565*C. elegans:* Strain BJH387 *flp-20(pk1596) X; frpr-3(ok3302) V*This studyN/A*C. elegans:* Strain AQ4144 *ljEx1165\[Pceh-10(3.6)::YC3.60::gpd-2 3′ UTR (pYLC233)(50);unc-122::rfp(50)\]*This studyN/A*C. elegans:* Strain AQ4187 *frpr-3(ok3302);ljEx1165*This studyN/A*C. elegans:* Strain AQ4188 *flp-20(ok2964);ljEx1165*This studyN/A*C. elegans:* Strain AQ4210 *flp-20(ok2964);ljEx1094;ljEx1165*This studyN/A*C. elegans:* Strain AQ4211 *frpr-3(ok3302);ljEx1167;ljEx1165*This studyN/A*C. elegans:* Strain AQ2766 *dop-2 (vs105)V;lite-1(ce314);ljIs114 X (ASH::ChR2)*This studyN/A*C. elegans:* Strain AQ2767 *npr-3(tm1583); lite-1(ce314);ljIs114 X (ASH::ChR2)*This studyN/A*C. elegans:* Strain AQ2768 *npr-5 (ok1583)V; lite-1(ce314);ljIs114 X (ASH::ChR2)*This studyN/A*C. elegans:* Strain AQ2769 *npr-13 (tm1504)V; lite-1(ce314);ljIs114 X (ASH::ChR2)*This studyN/A*C. elegans:* Strain AQ2770 *flp-6 (ok3056) V; lite-1(ce314);ljIs114 X (ASH::ChR2)*This studyN/A*C. elegans:* Strain AQ2772 *flp-21 (ok889)V; lite-1(ce314);ljIs114 X (ASH::ChR2)*This studyN/A*C. elegans:* Strain AQ2773 *mod-1 (ok103)V; lite-1(ce314);ljIs114 X (ASH::ChR2)*This studyN/A*C. elegans:* Strain AQ2779 *flp-4 II; lite-1(ce314);ljIs114 X (ASH::ChR2)*This studyN/A*C. elegans:* Strain AQ2781 *tyra-3 (ok325)X; lite-1(ce314);ljIs124 non-X (ASH::ChR2)*This studyN/A*C. elegans:* Strain AQ2782 *npr-1 (ad609)X; lite-1(ce314);ljIs124 non-X (ASH::ChR2)*This studyN/A*C. elegans:* Strain AQ2783 *flp-7 (ok2625)X; lite-1(ce314);ljIs124 non-X (ASH::ChR2)*This studyN/A*C. elegans:* Strain AQ2785 *flp-18 (dp99)X; lite-1(ce314);ljIs124 non-X (ASH::ChR2)*This studyN/A*C. elegans:* Strain AQ2786 *flp-20 (ok2964)X; lite-1(ce314);ljIs124 non-X (ASH::ChR2)*This studyN/A*C. elegans:* Strain AQ4405 *ser-7 (tm1325)X; ljIs105(Psra-6::ChR2)*This studyN/A*C. elegans:* Strain AQ4406 *tag-24 (ok371)X; ljIs105(Psra-6::ChR2)*This studyN/A*C. elegans:* Strain AQ4407 *ser-2 (pk1357)X; ljIs105(Psra-6::ChR2)*This studyN/A*C. elegans:* Strain AQ4408 *tyra-2 (tm1846)X; ljIs105(Psra-6::ChR2)*This studyN/A*C. elegans:* Strain AQ4409 *tyra-2 (tm1846)X; ljIs105(Psra-6::ChR2)*This studyN/A*C. elegans:* Strain AQ4410 *lgc-55 (tm2913)V; ljIs105(Psra-6::ChR2)*This studyN/A*C. elegans:* Strain AQ4411 *dop-6/C24A8.1 (ok2090)X; ljIs105(Psra-6::ChR2)*This studyN/A*C. elegans:* Strain AQ4412 *npr-1 (ad609)X; ljIs105(Psra-6::ChR2)*This studyN/A*C. elegans:* Strain AQ4413 *npr-2 (ok419)IV; ljIs105(Psra-6::ChR2)*This studyN/A*C. elegans:* Strain AQ4414 *npr-7 (ok527)X; ljIs105(Psra-6::ChR2)*This studyN/A*C. elegans:* Strain AQ4415 *npr-8 (tm1553)X; ljIs105(Psra-6::ChR2)*This studyN/A*C. elegans:* Strain AQ4416 *npr-10 (tm1568)X; ljIs105(Psra-6::ChR2)*This studyN/A*C. elegans:* Strain AQ4417 *npr-11 (ok594)X; ljIs105(Psra-6::ChR2)*This studyN/A*C. elegans:* Strain AQ4418 *npr-12 (tm1498)IV; ljIs105(Psra-6::ChR2)*This studyN/A*C. elegans:* Strain AQ4419 *flp-11 (tm2706)X; ljIs105(Psra-6::ChR2)*This studyN/A*C. elegans:* Strain AQ4420 *flp-17 (ok3587)IV; ljIs105(Psra-6::ChR2)*This studyN/A*C. elegans:* Strain AQ4421 *flp-18 (dp99)X; ljIs105(Psra-6::ChR2)*This studyN/A*C. elegans:* Strain AQ4422 *flp-19 (ok2460)X; ljIs105(Psra-6::ChR2)*This studyN/A

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, William Schafer (<wschafer@mrc-lmb.cam.ac.uk>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Animals {#sec4.3.1}

Strains were maintained on NGM (nematode growth medium) plates seeded with E. coli strain OP50 according to standard experimental procedures. Young adult hermaphrodite animals were used for all experiments. Where indicated, mutant alleles were backcrossed 3-6 x to our laboratory stock of N2 (wild-type). For a list of strains and transgene details, see [Table S1](#mmc1){ref-type="supplementary-material"} and the [Key Resources Table](#sec4.1){ref-type="sec"}.

### Microbe strains {#sec4.3.2}

The *Escherichia coli* OP50 strain was used as a food source for *C. elegans*.

Method Details {#sec4.4}
--------------

### Molecular Biology {#sec4.4.1}

Transgenes were cloned using the Multisite Gateway Three-Fragment cloning system (12537-023, Invitrogen) into pDESTR4R3 II. For transgenic reporter lines reported here, the length of the promoter (number of bases before ATG) for each gene is as follows: *E01H11.3*/*flp-20* 3081 bases; *C26F1.6*/*frpr-3* 2573 bases. For the list of reporter transgenic lines used to confirm the expression patterns of the above genes, see **Table S2**. For *frpr-3* RNAi, 700 bases of cDNA starting from the start codon was cloned in both the antisense or sense orientation. For *unc-31* RNAi, 703 bases of cDNA starting from the sequence GTTGTCGTGATGGAAGTGC was cloned in both the antisense or sense orientation. For *egl-21* RNAi, 652 bases of cDNA starting from the sequence GTGCTTTTGGTTGC was cloned in both the antisense or sense orientation. For cell-specific transgenic lines, the promoter lengths (bp upstream of ATG) used were: *Pmec-4* 1021 bp (TRNs), *Pgcy-5* 2012 bp (ASER), *Pgcy-7* 1198 bp (ASEL), *Pceh-10* 3583 bp (RID + others), *Pflp-2* 2000 bp (RID + others), *Pdes-2* 2581 bp (RID + others), P*ins-17* 2000 bp (RID + others), *Pflp-1* 1571 bp (AVK), *Psra-6* 2963 bp (ASH), *Psra-9* 3047 bp (ASK), and P*ttx-3* 243 bp sequence of the second intron (AIY). For cell-specific RNAi experiments, we knocked down expression in the following cells using the promoters in brackets: AIY (P*ttx-3*), ASH (P*sra-6*), ASK (P*sra-9*), AVK (P*flp-1*) and RID (four combinations: P*flp-2*/P*des-2*, P*flp-2*/P*ceh-10*, P*des-2*/P*ceh-10*, and P*ceh-10*/P*ins-17*).

### Behavioral assays {#sec4.4.2}

For all experiments, young adult hermaphrodite animals were used, therefore sample stratification was not required within each genotype/condition. For most experiments, measurements were scored by automated algorithm so blind scoring was not undertaken: see each subsection for details. For details of statistical tests, see the relevant Figure legend for each experiment and also the subsection "Quantification and Statistical Analysis." All recordings that passed the automated analysis pipeline were included in the final dataset.

*Locomotion (tap) arousal experiments*: 1-2 day old well-fed adult animals were used for all experiments. 16 hours before the experiment, late L4 animals were picked onto NGM plates seeded with 90 μL of OP50 bacteria left to grow at room temperature for 14-16 hours. 3-4 plates of \> 50-100 animals per plate were tested per trial, with each genotype tested in at least 3 trials. Multi worm tracking was performed using a Dinolite camera positioned above the plates, which recorded videos at 5 frames per second. An additional white LED backlight was used to improve contrast. Video recording was started 2 min after the plate was placed on the stage. Animals were recorded for 20 s before taps were applied and then for a further 5 min. Taps were applied manually to the bottom of the assay plate using the blunt end of a pencil (5 taps applied in \< 3 s). Tracks were analyzed using MATLAB (MathWorks) ([@bib63]). Speed plots show the absolute speed (including forward and backward locomotion). Arousal speed was determined by quantifying the average speed 10 s after tap, as the initial (acute) response is thought to largely include reversals ([@bib65]). The arousal integral (area under the curve) measurements obtained in the 5-20 s following tap stimulus (for 5x tap) or 2-10 s (for 1x tap) were performed using GraphPad Prism, with the baseline values used for each genotype being the speed measurements recorded before stimulus was applied. Note that arousal integrals for 1x taps are smaller than for 5x taps ([Figure 1](#fig1){ref-type="fig"}A); in addition, the presence of a *lite-1* mutation in the background affects locomotion and is likely to impact the absolute arousal measurements shown in [Figure 7](#fig7){ref-type="fig"}F and [Figure S7](#mmc1){ref-type="supplementary-material"}C. As speed measurements were conducted using an automated algorithm, genotypes were not blinded prior to analysis.

*For other stimulations:* odorants (1% in ethanol) benzaldehyde, (undiluted) 2-nonanone and (undiluted) diacetyl were dropped in front of the nose of the worm by mouth pipetting. Heat was applied by placing a heated platinum wire pick in front of the nose of the worm. "Pick" refers to animals being picked up using a platinum wire pick and immediately placed back onto the bacterial lawn. Taps were applied manually to the bottom of the assay plate using the blunt end of a pencil. Harsh touch refers to prodding of the worm body using a platinum wire pick. At least 5-10 animals were tested per condition, at least twice. For glycerol drop tests, 1 M glycerol was mouth pipetted close to the head as previously described ([@bib27]), with 5 minutes of acclimatization on the plate prior to application of the first stimulus. For this assay, reversal distance was counted by eye as the number of body bends observed during the reversal response.

*Channelrhodopsin experiments:* 1-2 day old well-fed adult animals were used for all experiments. For LED stimulation: for experiments with *flp-20* mutant animals, a custom setup was used as described in ([@bib27]); for experiments on *frpr-3* mutant animals and RNAi transgenic lines, a custom setup was used as in ([@bib4], [@bib5]) using 480 nm Luxeon star LEDs with 450 uw/mm^2^ power. In contrast to locomotion arousal experiments described above, these experiments used an automated tapper, which produces equivalent speed responses ([Figure S1](#mmc1){ref-type="supplementary-material"}C). *C. elegans* does not produce the co-factor all-trans retinal (ATR) required for ChR2 function. ATR (R2500 Sigma-Aldrich) was provided to animals by feeding as described in ([@bib61]). \> 20 animals were placed onto the seeded plate and at least 4 plates were assayed per condition and genotype on multiple days for all cross-modal sensitization behavioral experiments. Video recording was started 5 min after the plate was placed on the stage. For animals exposed to a pre-arousing tap, 1 tap was used, followed by a 20 s interval and then a 2 s blue light stimulation. For [Figure 1](#fig1){ref-type="fig"}B, the integrated transgene *Psra-6::ChR2* was used (*Psra-6::ChR2::YFP*). For all other experiments, the integrated transgene *ASH::ChR2* was used (*Pgpa-13::FLPase*, *Psra-6::FTF::ChR2::YFP*) ([@bib27]). "Wild-type" controls for these experiments were animals containing the *lite-1(ce314)* allele and the *ASH::ChR2* transgene. See [Table S1](#mmc1){ref-type="supplementary-material"} for full genotype information. As reversal distance measurements were conducted using an automated algorithm, genotypes were not blinded prior to analysis.

To test if 2-nonanone exposure could sensitize ASH-dependent reversals, 200 μL undiluted nonanone was spread with a pipette around the rim inside the lid of Petri dish. After 300 s acclimatization, the lid was changed from a control (no odorant) lid to the 2-nonanone-lid and blue light provided 40 s later. To test if tap in the presence of benzaldehyde could affect sensitization responses, 1% benzaldehyde in ethanol was spread evenly across the lid of the Petri dish and dried for 5 minutes in a fume cupboard. Control lids were prepared in the same way with ethanol alone. The protocol is as follows: 300 s acclimatization \> change lid from control to benzaldehyde-lid \> 20 s wait \> tap \> 20 s wait \> blue light (2 s). Two control groups were tested, in both groups the lid was changed to another control lid: one group was provided with an arousing tap stimulus and the other was not pre-aroused. For the *RID::Chrimson*/*ASH::ChR2* dual stimulation experiment, the protocol is 300 s acclimatization \> red light for 180 s (or no stimulus) \> tap (or no stimulus) \> 20 s wait \> blue light. Three groups were tested: prior to ASH activation with blue light, one group was stimulated with red light, one received a tap, and the naive group received neither stimuli. To provide dual-color light stimulation, a ring-shaped apparatus was constructed to contain 12 LEDs (6 red \[630 nm, 600 uw/mm^2^ Multicomp star\] and 6 blue \[480 nm, 350 uw/mm^2^, Luxeon star\]). The diameter of this ring is larger than the diameter of the 6-LED ring used for all other experiments, meaning that the blue light intensity is weaker than that in other assays (resulting in a reduced reversal response to optogenetic activation of ASH). LED stimulation was controlled by the Multi-Worm tracker software. For all experiments, reversal length was analyzed using MATLAB ([@bib5], [@bib27], [@bib63]).

*Touch assays:* Gentle body touch assays were performed on day 1 adults by stroking with an eyelash hair, as described ([@bib15]). Assays were conducted blind to the genotype of the strains.

*Off-food reversal rate:* The reversing assay was performed as previously described ([@bib60]). A single adult worm was removed from food, allowed to crawl for a few seconds until no traces of food were visible in its track, and then transferred to an empty 6 cm NGM plate. After 1 min, reversing events consisting of at least one body bend were counted over a 3 min period.

### Calcium imaging {#sec4.4.3}

*In microfluidics chip:* Calcium imaging on 1-2 day old adult animals was performed in custom-designed microfluidic devices as described (using mechanical stimulus module from [@bib21], [@bib20]). These experiments were performed on a Leica DMIRB inverted microscope using a 40x air objective (N.A. 0.75). Video sequences were captured using a Hamamatsu EM-CCD camera with 100 ms exposure time. Simultaneous dual color imaging was performed using a DV2 beamsplitter (Photometrics) containing a GFP(520 nm)/RFP(605 nm) filter set. Excitation light for fluorescent imaging was delivered through a projector system ([@bib72]). Stimuli were delivered as follows: for experiments where only a single chemical stimulus was provided, a 10 s pulse of 0.5 M glycerol in S-basal was delivered at t = 10 s after recordings were started, whereas for experiments where both mechanical and chemical stimuli were provided, a single (25 psi) mechanical stimulus to the anterior body was delivered at t = 30 s after the start of the recording, followed 20 s later by a 10 s pulse of 0.5 M glycerol (from t = 50-60 s). Note that based on genetic criteria (dependence on MEC-4/TRNs) the 25 psi stimulation is thought to be most equivalent to the tap stimulations applied in behavioral experiments ([@bib21], [@bib82]). Videos were recorded for 40-90 s following stimulus delivery. For analysis of calcium transients, fluorescence intensities for each frame were extracted using a custom MATLAB script ([@bib21], [@bib20]). The GCaMP3/tagRFP ratio (R) between intensity values was computed $\left( {{R = I_{Green\_ ROI}}/I_{Red\_ ROI}} \right)$ to minimize movement artifacts. GCaMP3 and RFP intensities were measured as the mean pixel intensity of the 100 brightest pixels in a circular region of interest (ROI) with a 10 pixel radius. Calcium traces were computed as the change in R from the baseline value $\left( {{{\Delta R}/R_{o}} = {\left( {R - R_{o}} \right)/R_{o}}} \right)$. Baseline values were computed as the mean R prior to stimulus delivery. Imaging was carried out in S-basal buffer (100mM NaCl, 0.05M phosphate buffer pH6.0, 5 μg/mL cholesterol). For two chemical stimulations (nonanone and glycerol), a Y-shaped connector (Norodson Medical, Y210-6005) was used to connect two chemical reservoirs and two off-chip solenoid valves for each chemical streamline, allowing for a rapid switch from the first stimulus to buffer and then to the second chemical stimulus. All quantification is provided as the ratio of GCaMP3 to tagRFP fluorescence intensity. As measurements were conducted using an automated algorithm, genotypes were not blinded prior to analysis.

*Glued procedure:* Calcium imaging of body touch stimulation of glued animals was performed essentially as described ([@bib42], [@bib73]), using a 1 s stimulus in the posterior end of the worm equidistant between the tail and the vulva. Stimulus was provided at t = 10 s after the start of the recording and videos were recorded for a total of 55 s. Images were recorded at 10 Hz using an iXon EM camera (Andor Technology), captured using IQ1.9 software (Andor Technology) and analyzed using a custom MATLAB (MathWorks) program ([@bib59]). Fluorescence intensity, F, was computed as the difference between the sum of pixel intensities and the faintest 10% pixels (background) within the ROI. As the calcium sensor Cameleon (YC3.60) was used in this experiment, fluorescence ratio R = F~YFP~/F~CFP~ (after correcting for bleed through) was used for computing ratio change, expressed as a percentage of R0 (the average R within the first 3 s of recording). Mechanical stimulation was carried out in Neuronal Buffer (145mM NaCl, 5mM KCl, 5mM CaCl~2~, 5mM MgCl~2~, 20mM glucose, 10mM HEPES, pH7.2). For comparison between mutant genotypes, calcium imaging was conducted blind to the genotype of the strains.

### *In vitro* GPCR activation assays {#sec4.4.4}

Cell-based activation assays were performed as described ([@bib9]). FRPR-3/C26F1.6 cDNA was cloned into the pcDNA3.1(+) TOPO expression vector (Thermo Fisher Scientific). Receptor activation was studied in Chinese hamster ovary cells (CHO) stably expressing apo-aequorin (mtAEQ) targeted to the mitochondria as well as the human Gα~16~ subunit. The CHO-K1 cell line (PerkinElmer, ES-000-A2) was used for receptor activation assays. CHO/mtAEQ/Gα~16~ cells were transiently transfected with the FRPR-3 cDNA construct or the empty pcDNA3.1(+) vector using the Lipofectamine transfection reagent (Thermo Fisher Scientific). Cells expressing the receptor were shifted to 28°C 1 day later, and collected 2 days post-transfection in BSA medium (DMEM/HAM's F12 with 15 mM HEPES, without phenol red, 0.1% BSA) loaded with 5 μM coelenterazine h (Thermo Fisher Scientific) for 4 h to reconstitute the holo-enzyme aequorin. Cells (25,000 cells/well) were exposed to synthetic peptides in BSA medium, and aequorin bioluminescence was recorded for 30 s on a MicroBeta LumiJet luminometer (PerkinElmer, Waltham Massachusetts) in quadruplicate. For dose-response evaluations, after 30 s of ligand-stimulated calcium measurements, Triton X-100 (0.1%) was added to the well to obtain a measure of the maximum cell Ca^2+^ response. BSA medium without peptides was used as a negative control and 1 μM ATP was used to check the functional response of the cells. Cells transfected with the empty vector were used as a negative control (not shown). EC~50~ values were calculated from dose-response curves, constructed using a nonlinear regression analysis, with sigmoidal dose-response equation (Prism 6.0).

### Confocal microscopy {#sec4.4.5}

Images were acquired using a Zeiss LSM 710 or 780 and z stacks generated using Fiji (ImageJ).

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

The number of animals and replicates used per experiment is described in detail in the "Methods Details" subsection for each assay and in the relevant Figure legends. Specifically, for the main behavior tests: locomotor (tap) assays were conducted \> 3 times with at least 3 plates of 50-100 animals each; cross-modal sensitization experiments were conducted with \> 4 trials per condition of \> 20 animals each.

Statistical analysis for all experiments was performed using GraphPad Prism 6.0. In general, where two groups were compared, an unpaired t test was used. Where multiple groups tested with a single condition were compared, a one-way ANOVA with Sidak's multiple comparisons post-test was used. Where multiple groups tested with multiple conditions were compared, a two-way ANOVA with Fisher's multiple comparisons post-test was used. Where appropriate, a D'Agostino & Pearson normality test was conducted to assess if the data fit a normal distribution.

Data and Software Availability {#sec4.6}
------------------------------

All data are available in electronic files.

Supporting Citations {#app3}
====================

The following reference appears in the [Figure S1](#mmc1){ref-type="supplementary-material"} legend in the Supplemental Information: [@bib85].

Supplemental Information {#app2}
========================

Document S1. Figures S1--S7 and Tables S1 and S2Document S2. Article plus Supplemental Information
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